This brand name is authorized in France
The drug ARPHOS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Magnesium oxide
UNII T42NAD2KHC - MAGNESIUM GLUCONATE
|
|
Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding. |
|
2
Calcium glycerophosphate
UNII XWV9Z12C1C - CALCIUM GLYCEROPHOSPHATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A13A | Tonics | A Alimentary tract and metabolism → A13 Tonics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 65979518 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
